The role of viral agents in aetiopathogenesis of acute rheumatic fever.
The reason why abnormal immune response exists in acute rheumatic fever is not exactly explained. The influence of co-pathogens like certain viruses were mentioned regarding the initiation of the immunological reaction in acute rheumatic fever patients by several authors since 1970. This study was designed to find the role or effect of some viral infections in the development of rheumatic fever. In this study, 47 cases with acute rheumatic fever (acute rheumatic arthritis, acute rheumatic carditis, and chorea), 20 cases with chronic rheumatic fever, 20 cases with streptococcal pharyngitis, and 20 healthy age- and gender-matched control cases were involved. Serological and molecular tests were made including hepatitis B virus, hepatitis C virus, rubella virus, herpes simplex virus (HSV group 1), and Epstein-Barr virus (EBV). HBsAg, rubella IgM and EBV IgM positivity were not seen in any of patients with rheumatic fever. Although antiHBs seropositivity was higher in the control group, it was not statistically significant (p > 0.05). There was no difference in rubella IgG, HSV IgM seropositivity, either (p > 0.05). EBV DNA was searched by the polymerase chain reaction technique; due to the latent nature of the virus, no significant difference was found between the control group and the other groups (p > 0.05). In this study, no positive correlation could be found to support the synergism theories regarding the streptoccocus infection and viral infections in the development of acute rheumatic fever. Only EBV DNA positivity was found in all acute rheumatic fever cases but not in the control group may lead to further studies with larger series of patients.
Olgunturk
Rana
R
Department of Pediatric Cardiology, Gazi University Faculty of Medicine, Besevler, Ankara, Turkey.
Okur
Ilyas
I
Cirak
Meltem Y
MY
Oguz
Ayse Deniz
AD
Akalin
Nursel
N
Turet
Sevgi
S
Tunaoglu
Sedef
S
D000293:Adolescent; D001168:Arthritis / Q000150:complications / Q000821:virology*; D016022:Case-Control Studies; D002648:Child; D002819:Chorea / Q000150:complications / Q000821:virology*; D002908:Chronic Disease; D004279:DNA, Viral / Q000032:analysis; D005260:Female; D006801:Humans; D007107:Immune System; D007074:Immunoglobulin G / Q000378:metabolism; D007075:Immunoglobulin M / Q000378:metabolism; D008297:Male; D009205:Myocarditis / Q000150:complications / Q000821:virology*; D010612:Pharyngitis / Q000150:complications / Q000821:virology*; D016133:Polymerase Chain Reaction / Q000379:methods; D012213:Rheumatic Fever / Q000209:etiology* / Q000821:virology*; D014777:Virus Diseases / Q000150:complications* / Q000175:diagnosis
D004279:DNA, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M
Turk J Pediatr. 1999 Apr-Jun;41(2):201-6
10770659
Turk J Pediatr. 1988 Jan-Mar;30(1):1-8
3232220
Adv Vet Sci Comp Med. 1982;26:155-71
6758537
Heart. 2005 Jan;91(1):87-8
15604341
Indian J Pediatr. 2004 Oct;71(10):915-9
15531835
J Med Virol. 2002 Mar;66(3):360-9
11793388
J Egypt Public Health Assoc. 1990;65(5-6):609-16
2134095
J Infect Dis. 1980 Feb;141(2):172-6
6965977
Rheum Dis Clin North Am. 1998 May;24(2):237-59
9606757
Br Med Bull. 1985 Jan;41(1):63-9
3882189
Rheum Dis Clin North Am. 1997 Aug;23(3):677-95
9287382
Circulation. 1993 Jun;87(6):1974-8
8504512
Am J Cardiol. 1972 Feb;29(2):231-40
4336266
J Clin Lab Immunol. 1984 Mar;13(3):133-6
6609239
Clin Rheumatol. 1983 Sep;2(3):217-22
6088158
Indian J Pediatr. 1993 Mar-Apr;60(2):289-98
8244506
J Assoc Physicians India. 1989 Sep;37(9):582-5
2561125
N Engl J Med. 1985 Aug 29;313(9):580-1
4022093
Am Heart J. 1970 Oct;80(4):556-61
5471218
Pediatr Cardiol. 1992 Oct;13(4):204-7
1518738
N Engl J Med. 1985 Apr 11;312(15):991-2
3974690
Annu Rev Med. 1984;35:469-79
6326662
Lancet. 1973 Sep 1;2(7827):507
4125029
J Trop Pediatr. 1995 Dec;41(6):341-3
8606441